Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079937
Status:
COMPLETED
Last Update Posted:
2012-04-11
First Post:
2004-03-18
Brief Title:
Efficacy and Safety of Omalizumab in Children 6 - 12 Years With Moderate-severe Inadequately Controlled Allergic Asthma
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis